CAS 1404-15-5
:Nogalamicina
Descripción:
Nogalamicina es un antibiótico antraciclínico de origen natural que se deriva de la bacteria *Micromonospora* especies. Se caracteriza por su compleja estructura policíclica, que incluye un componente de azúcar y un componente aglicona, contribuyendo a su actividad biológica. Nogalamicina exhibe potentes propiedades antitumorales, principalmente a través de su capacidad para intercalarse en el ADN, interrumpiendo los procesos de replicación y transcripción, lo que finalmente conduce a la muerte celular. Su mecanismo de acción es similar al de otras antraciclinas, como la doxorrubicina, pero tiene un perfil único que puede ofrecer ventajas en ciertos contextos terapéuticos. El compuesto ha mostrado actividad contra varias líneas celulares de cáncer, lo que lo convierte en un tema de interés en la investigación del cáncer. Sin embargo, al igual que muchos agentes quimioterapéuticos, también puede exhibir citotoxicidad a las células normales, lo que requiere una cuidadosa consideración en las aplicaciones clínicas. La investigación continúa explorando sus posibles usos, estrategias de dosificación óptimas y formas de mitigar los efectos secundarios asociados con su uso en la terapia del cáncer.
Fórmula:C39H49NO16
InChI:InChI=1S/C39H49NO16/c1-14-32(49-7)39(4,52-10)33(50-8)36(53-14)54-19-13-37(2,48)24(34(47)51-9)15-11-16-21(27(43)20(15)19)28(44)22-18(41)12-17-30(23(22)26(16)42)55-35-29(45)25(40(5)6)31(46)38(17,3)56-35/h11-12,14,19,24-25,29,31-33,35-36,41,43,45-46,48H,13H2,1-10H3/t14-,19-,24-,25-,29-,31+,32-,33-,35+,36-,37-,38+,39+/m0/s1
Clave InChI:InChIKey=KGTDRFCXGRULNK-JYOBTZKQSA-N
SMILES:O=C1C=2C3=C([C@@]4(C)O[C@@](O3)([C@@H](O)[C@H](N(C)C)[C@H]4O)[H])C=C(O)C2C(=O)C=5C1=CC6=C(C5O)[C@@H](O[C@H]7[C@H](OC)[C@@](OC)(C)[C@@H](OC)[C@H](C)O7)C[C@](C)(O)[C@@H]6C(OC)=O
Sinónimos:- 2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylic acid, 11-((6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R-(2alpha,3beta,4alpha,5beta,6alpha,11beta,13alpha,14alpha))-
- 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-
- 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, [2R-(2α,3β,4α,5β,6α,11β,13α,14α)]-
- Antibiotic 205t3
- Antibiotic NSC 70845
- Antibiotic from Streptomyces nogalater
- Methyl 11-((6-desoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy)-4-dimethylamino-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-2,6-epoxy-2H-naphthaceno(1,2-b)-oxocin-14-carboxylat
- Nogalamicina
- Nogalamicina [INN-Spanish]
- Nogalamycin [USAN:INN]
- Nogalamycine
- Nogalamycine [INN-French]
- Nogalamycinum
- Nogalamycinum [INN-Latin]
- Nogalamyicn
- Nogalomycin
- Nsc 70845
- U 15167
- methyl (2R,3S,4R,5R,6R,11S,13S,14R)-11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methylhexopyranosyl)oxy]-4-(dimethylamino)-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-3,4,5,6,9,11,12,13,14,16-decahydro-2H-2,6-epoxytetraceno[1,2-b]oxocine-14-carboxylate
- methyl (2S,3S,4R,5R,6S,11S,13S,14R)-11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methylhexopyranosyl)oxy]-4-(dimethylamino)-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-3,4,5,6,9,11,12,13,14,16-decahydro-2H-2,6-epoxytetraceno[1,2-b]oxocine-14-carboxylate
- methyl 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methylhexopyranosyl)oxy]-4-(dimethylamino)-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-3,4,5,6,9,11,12,13,14,16-decahydro-2H-2,6-epoxytetraceno[1,2-b]oxocine-14-carboxylate
- Nogalamycin
- 2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, [2R-(2α,3β,4α,5β,6α,11β,13α,14α)]-
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 4 productos.
2,6-Epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid, 11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R,3S,4R,5R,6R,11S,13S,14R)-
CAS:Fórmula:C39H49NO16Pureza:97%Forma y color:SolidPeso molecular:787.8035Nogalamycin
CAS:Nogalamycin is an anthracycline antibiotic with antitumor properties produced by soil bacteria Streptomyces nogalater.Fórmula:C39H49NO16Pureza:98%Forma y color:SolidPeso molecular:787.812Nogalamycin
CAS:Producto controlado<p>Applications Nogalamycin (cas# 1404-15-5) is a compound useful in organic synthesis.<br></p>Fórmula:C39H49NO16Forma y color:NeatPeso molecular:787.803



